glp-1 endometriosis study Peritoneal Incretin Deficiency and Tirzepatide as a Multi-Axis Adjuvant Hypothesis in Treatment-Refractory Endometriosis: A Mechanistic Framework Linking Metabolism, Immunity, Fibrosis, and Nociception GLP-1 in peritoneal fluid in

Hernandez, A

Based on your goals, well outline personalized options and answer any questions you have before moving forward

Enhanced Insulin Secretion: Activation of both GIP and GLP-1 receptors stimulates glucose-dependent insulin release from pancreatic -cells, improving postprandial and fasting glycemia while minimizing the risk of hypoglycemia

GLP-1 medications also carry some serious (but rare) warnings: Potential risk of thyroid C-cell tumors (observed in rodent studies, unclear relevance in humans) Risk of gallbladder problems Pancreatitis (rare but documented) Hair loss (temporary, related to rapid weight loss rather than the drug itself) One notable advantage of GLP-1 medications: they do not cause cognitive dysfunction, do not carry teratogenicity warnings as severe as topiramate, and are not controlled substances

GLP-1s slow gastric emptying, so a heavy meal right after a dose can mean real nausea

This hormone helps regulate appetite, insulin secretion, and gastric emptying after meals